Rajeshwari Sridhara

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• FDA pooled analysis of overall survival according to depth of response as a continuous variable in frontline advanced immuno-oncology renal cell carcinoma trials.

  Journal of Clinical Oncology · 2024-01-29

• FDA analysis of treatment-free survival in frontline advanced immuno-oncology–VEGF TKI renal cell carcinoma trials.

  Journal of Clinical Oncology · 2023-06-01 · 2 citations

• FDA pooled analysis of overall survival according to depth of response as a continuous variable in frontline advanced immuno-oncology renal cell carcinoma trials.

  Journal of Clinical Oncology · 2023-06-01 · 1 citations

• Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration—Melanoma Research Alliance Public Workshop

  Clinical Cancer Research · 2020-11-13 · 11 citations

• Abstract PD4-08: An FDA analysis of survival outcomes comparing adjuvant paclitaxel and trastuzumab trial (APT) to an external control from historical clinical trials

  Cancer Research · 2020-02-15